GO
Loading...

Medicine

More

  • ATLANTA, Aug 21- Two American aid workers who just weeks ago were gravely ill with Ebola they contracted in Liberia now pose no health risk to the public after being cleared of the virus and released from an Atlanta hospital, one of their doctors said on Thursday.

  • ATLANTA, Aug 21- Two American aid workers discharged from an Atlanta hospital after being treated for Ebola pose no health risk to the public, an Emory University Hospital doctor said on Thursday.

  • New restrictions on hydrocodone to take effect Thursday, 21 Aug 2014 | 11:06 AM ET

    The move, announced in a federal notice, comes more than a decade after the Drug Enforcement Administration first recommended reclassifying hydrocodone due to its risks for abuse and addiction. But last year the FDA changed its position, citing the national epidemic of overdoses and deaths tied to prescription painkillers known as opioids.

  • JOHANNESBURG, Aug 21- Surviving sickness can make you stronger. "If anything, I think it is teaching us something," Mustapha Sidiki Kaloko, the African Union's Commissioner for Social Affairs, told reporters in Addis Ababa this month.

  • Aug 21- Eli Lilly and Co said its experimental psoriasis drug was found to be more effective in clearing skin than a generic treatment and a placebo in late-stage studies. The most common inflammatory disease in the United States- it can occur on any part of the body- it is associated with diabetes and heart disease.

  • ABIDJAN, Aug 21- An American doctor who contracted Ebola treating victims of the deadly virus in Liberia has recovered and will be discharged on Thursday by the U.S. hospital that treated him with an experimental drug, his charity said.

  • NEW YORK, Aug 20- An experimental drug from Tekmira Pharmaceuticals Corp helped lab monkeys recover from the most deadly strain of Marburg virus, a close cousin of Ebola, even after symptoms appeared, scientists reported on Wednesday.

  • MONROVIA, Aug 20- Police in the Liberian capital Monrovia fired tear gas on Wednesday to disperse a stone-throwing crowd agitating to leave a neighbourhood placed under quarantine because of the Ebola virus, witnesses said. The rundown area has been hit by Ebola, which has killed more than 1,200 people in Guinea, Sierra Leone and Liberia and five in Nigeria.

  • MONROVIA, Aug 20- Police in the Liberian capital Monrovia fired tear gas on Wednesday to disperse a stone-throwing crowd agitating to leave a neighbourhood placed under quarantine because of the Ebola virus. Witnesses said there were no injuries.

  • *Liberia records most new deaths, worries over Monrovia. The epidemic of the hemorrhagic disease, which can kill up to 90 percent of those it infects, is ravaging the three small West African states of Liberia, Sierra Leone and Guinea, and also has a toehold in Nigeria, Africa's biggest economy.

  • FDA approves new drug for rare genetic disease Tuesday, 19 Aug 2014 | 6:00 PM ET

    Cerdelga is from Genzyme, the specialty drugmaker that introduced the first drug for Gaucher's disease 20 years ago. The oral treatment could serve as an alternative to Genzyme's best-selling drug Cerezyme, which is given intravenously. Genzyme says it will soon release pricing for its new drug.

  • UPDATE 1-GameStop CEO undergoes surgery for brain tumor Tuesday, 19 Aug 2014 | 12:05 PM ET

    Aug 19- GameStop Corp, the world's largest retailer of videogame products, said Chief Executive Paul Raines underwent an unexpected surgery last week for a small cancerous brain tumor. GameStop also said the six-week treatment period will not interfere with Raines' "continued leadership" of the company.

  • GameStop CEO treated for cancerous brain tumor Tuesday, 19 Aug 2014 | 10:24 AM ET

    NEW YORK— GameStop Corp. said Tuesday that its CEO, Paul Raines, had surgery last week to remove a cancerous brain tumor. The prognosis for a full recovery is "very good," GameStop said in a filing with the Securities and Exchange Commission.

  • GameStop CEO undergoes surgery for brain tumor Tuesday, 19 Aug 2014 | 9:52 AM ET

    Aug 19- GameStop Corp, the world's largest retailer of videogame products, said Chief Executive Paul Raines underwent an unexpected surgery last week for a small cancerous brain tumor. Raines, who will be undergoing chemotherapy, will restrict his travel during the expected six week of treatment, the company said in a regulatory filing on Tuesday.

  • The epidemic of the hemorrhagic disease, which can kill up to 90 percent of those it infects, is ravaging the three small West African states of Liberia, Sierra Leone and Guinea, and also has a toehold in Nigeria, Africa's biggest economy. Between Aug. 14-16, Liberia recorded the most new deaths, 53, followed by Sierra Leone with 17, and Guinea with 14..

  • ALS raises over $13 million since July 29th     Monday, 18 Aug 2014 | 6:25 AM ET

    CNBC's Andrew Ross Sorkin looks back on some of the best ice bucket challenge videos from last week, including from Bill Gates, saying the campaign has now hit China.

  • FDA approves Biogen's MS drug Plegridy Friday, 15 Aug 2014 | 7:27 PM ET

    CAMBRIDGE, Mass.— Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.

  • Aug 15- Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. Achievement of 100 percent cure rate confirms the competitive profile of NS5A, Wells Fargo Securities analyst Brian Abrahams wrote in a note.

  • FDA clears Avastin for late-stage cervical cancer Friday, 15 Aug 2014 | 10:44 AM ET

    WASHINGTON— The Food and Drug Administration has approved Genentech's Avastin for a new use against late-stage cervical cancer, the seventh indication for the blockbuster biotech drug. The FDA approved the drug late Thursday for women with cervical cancer that is persistent, recurrent or has spread to other parts of the body.

  • Achillion rises on hepatitis C drug study Friday, 15 Aug 2014 | 9:05 AM ET

    NEW YORK— Achillion Pharmaceuticals climbed in premarket trading Friday after the company reported promising results from a small clinical trial of an experimental hepatitis C drug. Shares of Achillion Pharmaceuticals Inc. jumped $1.55, or 18.4 percent, to $9.99 in premarket trading about 30 minutes before the market opening.